Digital Diabetes Remission Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a multicentre, open-label Randomised Controlled Trial run in the United Kingdom. The main aims are to assess whether the Habitual Remission Programme (digital therapeutics + 12-week 800kcal/day low-energy diet, delivered remotely) is more likely to lead to weight loss and remission in adults with type 2 diabetes, when compared to standard of care.
Epistemonikos ID: 50aea86c2d8663ab7b02d95482fe0837eaf279ab
First added on: May 14, 2024